This is an "Outlier" stock that absolutely doesn't belong in the single digits
Been saying for a while now that this "outlier" will not last. Their platform alone is worth more than current stock price..leave alone the promising hepatitis B cure....ARC-520 that they have. If and once they demonstrate safety in humans..as italians would say...."fogeet about it!"
Volume is great. In my opinion, some institutional/hedge fund is buying... We might see more analyst coverage in future. May also attract other funds and give more visibility. I see a multi-bagger in due time.
I agree. They've been stealthily accumulating avoiding driving it over 4% on any given day except today ue to volume. I told one guy he was insane to sell at $2.55...now he only moans for a pullback. Also notice ..very litle if any selling. hasn't closed down even 1% for last few weeks.
Agree except I have to believe that ARWR's DPC platform alone is worth multiples of the current stock price. Then, add in their promising HBV ARC-520 and Dirk's $30 price target seems eminently reasonable and achievable (in a year or 2).
I bought a full position at or near the bottom and my biggest concern is whether I will be able to resist selling before ARWR's price advance has run its course.